*Fumihiko Ueno1,2,3, Yusuke Iwata9, Shiori Honda3, Guillermo Horga4,5, Clifford M Cassidy6, Edgardo Torres-Carmona1,7, Jianmeng Song1,7, Vincenzo de Luca2,7,8, Sakiko Tsugawa3, Yoshihiro Noda3, Mahavir Agarwal2,7,8, Philip Gerretsen1,2,7,8, Shinichiro Nakajima3, Ariel Graff-Guerrero1,2,7,8
(1. Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada, 2. Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada, 3. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, 4. Department of Psychiatry, Columbia University, New York, NY, USA, 5. Division of Translational Imaging, New York State Psychiatric Institute, New York, NY, USA, 6. The Royal’s Institute of Mental Health Research Affiliated with the University of Ottawa, Ottawa, Ontario, Canada, 7. Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada, 8. Campbell Family Mental Health Research Institute, CAMH, Toronto, Ontario, Canada, 9. Department of Neuropsychiatry, University of Yamanashi, Faculty of Medicine, Yamanashi, Japan)
Keywords:Neuromelanin, Dopamine, Schizophrenia, Substantia nigra, Clozapine
Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.